Clinical trial
Levetiracetam for Benign Rolandic Epilepsy
NCT00181116 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00181116 |
|---|---|
| Title | Levetiracetam for Benign Rolandic Epilepsy |
| Official title | Efficacy of Levetiracetam for Language Dysfunction Associated With Benign Epilepsy With Centrotemporal Spikes |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 6 |
| Start date | Mar 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 27, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: